Our vision is for a world without MND, sooner. To achieve this, we need to fund interdisciplinary partnerships, collaborate, and fast-track the research pathways most likely to translate to clinical benefits for people with MND.
THE MNDi Foundation and The Murdoch MND Research Partnership
The MNDi Foundation funds The Murdoch MND Research Partnership headed by Professor Sue Fletcher. The partnership is a multi-institutional collaboration that brings together research and clinical expertise to accelerate the development of genetic drugs that directly target pathways involved in MND pathology and motor neuron disruption.
Research we fund
The teams we are currently funding are exclusively focussed on understanding mechanisms in MND and developing RNA therapeutics for inherited and acquired MND. This means therapies are developed specifically to target pathways that are disrupted in motor neurons and supporting cells.